Related Experiment Videos

[Percutaneous coronary angioplasty in chronic coronary disease with single and multiple obstructed vessels (analysis

P Romaniuk1, C Kothe, W Schöpke

  • 1Institut für kardiovaskuläre Diagnostik, Bereich Medizin (Charité) der Humboldt-Universität zu Berlin.

Radiologia Diagnostica
|January 1, 1990
PubMed

Insights

Variant 3 of percutaneous transluminal coronary angioplasty (PTCA) is an effective routine method for ischemic heart disease, achieving 86% primary effectiveness. However, it requires longer procedure times for multiple vessel PTCA, limiting its use to specific patient groups.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Context:

  • Analysis of 315 percutaneous transluminal coronary angioplasties (PTCA) performed between 1978-1988.
  • Evaluation of 261 patients diagnosed with ischemic heart disease.
  • Comparison of three distinct PTCA procedural variants.

Purpose:

  • To assess the primary effectiveness, failure rates, complications, material costs, and procedural/fluoroscopy duration of different PTCA variants.
  • To identify an applicable routine method for PTCA in ischemic heart disease patients.

Summary:

  • Variant 3, incorporating soft-tip-applicators, a flat profile balloon catheter, Kaltenbach long-wire technique, streptokinase instrument rinsing, and permanent instrument infusion, emerged as the most applicable routine method.
  • This variant demonstrated a primary effectiveness of 86%.
  • For multi-vessel PTCA, Variant 3 led to significantly prolonged investigation and fluoroscopy times, suggesting its suitability for selected patient cohorts.

Impact:

  • Identifies an optimal PTCA technique for routine application in ischemic heart disease.
  • Highlights the trade-offs between effectiveness and procedural duration for multi-vessel interventions.
  • Provides data to guide the selection of PTCA strategies based on patient complexity and resource utilization.

Related Concept Videos